Page last updated: 2024-10-29

iproniazid and Asthma

iproniazid has been researched along with Asthma in 3 studies

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LOREDO HILL, J1
MIRABILE, E1
GIRARD, JP1

Other Studies

3 other studies available for iproniazid and Asthma

ArticleYear
[Clinical evaluation of nialamide in bronchial asthma].
    Revista. Asociacion Medica Mexicana, 1961, Apr-25, Volume: 41

    Topics: Asthma; Iproniazid; Nialamide; Psychopharmacology

1961
[Action of a monoaminooxidase inhibitor (nialamide) on the asthmatic state].
    Gazzetta medica italiana, 1961, Volume: 120

    Topics: Asthma; Iproniazid; Nialamide; Oxidoreductases; Psychopharmacology

1961
[THE ROLE OF ADENOSINE TRIPHOSPHATE (ATP) IN THE INTRAPLATELET FIXATION OF SEROTONIN].
    Schweizerische medizinische Wochenschrift, 1963, Oct-12, Volume: 93

    Topics: Adenosine Triphosphate; Arthritis; Arthritis, Rheumatoid; Asthma; Blood Platelets; Enzyme Inhibitors

1963